These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7798679)

  • 21. Guinea pig and human cytomegaloviruses do not share cross-reactive neutralizing epitopes.
    Adler SP; Shaw KV; McVoy M; Burke RL; Liu H
    J Med Virol; 1995 Sep; 47(1):48-51. PubMed ID: 8551258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed type hypersensitivity to human cytomegalovirus.
    Gupta R; Gonczol E; Manning ML; Starr S; Johnson B; Murphy GF; Plotkin SA
    J Med Virol; 1993 Feb; 39(2):109-17. PubMed ID: 8387567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates.
    Sachs GW; Simmons RL; Balfour HH
    Vaccine; 1984 Sep; 2(3):215-8. PubMed ID: 6099649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current prospects for immunization against cytomegaloviral disease.
    Adler SP
    Infect Agents Dis; 1996 Jan; 5(1):29-35. PubMed ID: 8789597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine.
    Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
    Birth Defects Orig Artic Ser; 1984; 20(1):271-87. PubMed ID: 6329367
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.
    Stowell JD; Mask K; Amin M; Clark R; Levis D; Hendley W; Lanzieri TM; Dollard SC; Cannon MJ
    BMC Infect Dis; 2014 Nov; 14():568. PubMed ID: 25388365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development.
    He H; Rinaldo CR; Morel PA
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1603-10. PubMed ID: 9049367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.
    Lilleri D; Gerna G
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28008685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
    Farrell HE; Bruce K; Stevenson PG
    J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.
    Quinnan GV; Delery M; Rook AH; Frederick WR; Epstein JS; Manischewitz JF; Jackson L; Ramsey KM; Mittal K; Plotkin SA
    Ann Intern Med; 1984 Oct; 101(4):478-83. PubMed ID: 6089634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
    Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
    J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
    Boppana SB; Britt WJ
    Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants.
    Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
    Lancet; 1984 Mar; 1(8376):528-30. PubMed ID: 6142252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
    Wang JB; Adler SP; Hempfling S; Burke RL; Duliège AM; Starr SE; Plotkin SA
    J Infect Dis; 1996 Aug; 174(2):387-92. PubMed ID: 8699071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancy in impact of maternal milk on vertical transmission between Hepatitis B virus and Human cytomegalovirus.
    Wang T; Wang M; Duan G; Chen X; He Y
    Int J Infect Dis; 2015 Aug; 37():1-5. PubMed ID: 26072037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative magnitude and kinetics of human cytomegalovirus-specific CD4⁺ and CD8⁺ T-cell responses in pregnant women with primary versus remote infection and in transmitting versus non-transmitting mothers: Its utility for dating primary infection in pregnancy.
    Fornara C; Furione M; Arossa A; Gerna G; Lilleri D
    J Med Virol; 2016 Jul; 88(7):1238-46. PubMed ID: 26680747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
    Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
    J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.
    Plotkin SA; Higgins R; Kurtz JB; Morris PJ; Campbell DA; Shope TC; Spector SA; Dankner WM
    Transplantation; 1994 Dec; 58(11):1176-8. PubMed ID: 7992358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprophylaxis against cytomegalovirus disease.
    Adler SP
    Scand J Infect Dis Suppl; 1995; 99():105-9. PubMed ID: 8668931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
    Permar SR; Schleiss MR; Plotkin SA
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.